Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2015 | Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma | JIA-HUEI TSAI ; Lin Y.-L.; Cheng Y.-C.; CHIEN-CHUAN CHEN ; LIANG-IN LIN ; LI-HUI TSENG ; Cheng M.-L.; JAU-YU LIAU ; YUNG-MING JENG | Modern Pathology | 32 | 30 | |
2001 | Absence of statistically significant correlation between disparity for the minor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation [1] | Lin M.-T.; Gooley T.; Hansen J.A.; LI-HUI TSENG ; Martin E.G.; Singleton K.; Smith A.G.; Mickelson E.; Petersdorf E.W.; Martin P.J. | Blood | 46 | 44 | |
1993 | Alpha-thalassemia in the four major aboriginal groups in Taiwan | Ko T.-M.; Chen T.-A.; Hsieh M.-I.; LI-HUI TSENG ; Hsieh F.-J.; Chuang S.-M.; Lee T.-Y. | Human Genetics | 23 | 20 | |
1994 | Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection | Ko T.-M.; LI-HUI TSENG ; MEI-HWEI CHANG ; Chen D.-S.; Hsieh F.-J.; Chuang S.-M.; Lee T.-Y. | Archives of Gynecology and Obstetrics | 38 | 29 | |
2011 | Analysis of hematopoietic stem cell transplant engraftment: Use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy | Lin M.-T.; LI-HUI TSENG ; Beierl K.; Harada S.; Hafez M.J.; Eshleman J.R.; Gocke C.D. | Diagnostic Molecular Pathology | 5 | 5 | |
2011 | Analysis of MTCOI and MTCYB sequence variations in eight population groups living in Taiwan | HSIAO-LIN HWA ; Lin C.-Y.; Ko T.-M.; Yin H.-Y.; LI-HUI TSENG ; Su Y.-N.; JAMES CHUN-I LEE | Romanian Journal of Legal Medicine | 4 | 3 | |
2021 | Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort | KUO-HSING CHEN ; LIANG-IN LIN ; CHANG-TSU YUAN ; LI-HUI TSENG ; Chao, Yu-Liang; YI-HSIN LIANG ; JIN-TUNG LIANG ; BEEN-REN LIN ; ANN-LII CHENG ; KUN-HUEI YEH | British journal of cancer | 0 | 0 | |
2016 | BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer | KUO-HSING CHEN ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; LI-HUI TSENG ; LIANG-IN LIN ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | Medical Oncology | 17 | 16 | |
1992 | Carrier detection and prenatal diagnosis of alpha-thalassemia of Southeast Asian deletion by polymerase chain reaction | Ko T.-M.; LI-HUI TSENG ; Hsieh F.-J.; Hsu P.-M.; Lee T.-Y. | Human Genetics | 49 | 46 | |
2016 | Case report: Mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance | KUO-HSING CHEN ; CHANG-TSU YUAN ; LI-HUI TSENG ; CHIA-TUNG SHUN ; KUN-HUEI YEH | Journal of Hematology and Oncology | 15 | 13 | |
2015 | Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations | YI-HSIN LIANG ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; LI-HUI TSENG ; LIANG-IN LIN ; YIH-LEONG CHANG ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 4 | 4 | |
2015 | Challenges posed to pathologists in the detection of KRAS mutations in colorectal cancers | Dudley J.; LI-HUI TSENG ; Rooper L.; Harris M.; Haley L.; Chen G.; Gocke C.D.; Eshleman J.R.; Lin M.-T. | Archives of Pathology and Laboratory Medicine | 33 | 31 | |
1997 | Characterization of factor-independent variants derived from TF-1 hematopoietic progenitor cells: The role of the Raf/MAP kinase pathway in the anti-apoptotic effect of GM-CSF | Chao J.-R.; Chen C.-S.; Wang T.-F.; LI-HUI TSENG ; Tsai J.-J.; Kuo M.-L.; Yen J.J.-Y.; Yang Yen H.-F. | Oncogene | 14 | 14 | |
2015 | Clinical detection and categorization of uncommon and concomitant mutations involving BRAF | Zheng G.; LI-HUI TSENG ; Chen G.; Haley L.; Illei P.; Gocke C.D.; Eshleman J.R.; Lin M.-T. | BMC Cancer | 76 | 76 | |
2019 | Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing | Lokhandwala P.M.; LI-HUI TSENG ; Rodriguez E.; Zheng G.; Pallavajjalla A.; Gocke C.D.; Eshleman J.R.; Lin M.-T. | BMC Cancer | 30 | 31 | |
2017 | Clinical mutational profiling of 1006 lung cancers by next generation sequencing | Illei P.B.; Belchis D.; LI-HUI TSENG ; Nguyen D.; De Marchi F.; Haley L.; Riel S.; Beierl K.; Zheng G.; Brahmer J.R.; Askin F.B.; Gocke C.D.; Eshleman J.R.; Forde P.M.; Lin M.-T. | Oncotarget | 26 | 24 | |
2019 | Clinical validation of coexisting driver mutations in colorectal cancers | Zheng G.; LI-HUI TSENG ; Haley L.; Ibrahim J.; Bynum J.; Xian R.; Gocke C.D.; Eshleman J.R.; Lin M.-T. | Human Pathology | 6 | 8 | |
2019 | Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens | LI-HUI TSENG ; De Marchi F.; Pallavajjalla A.; Rodriguez E.; Xian R.; Belchis D.; Gocke C.D.; Eshleman J.R.; Illei P.; Lin M.-T. | American Journal of Clinical Pathology | 6 | 5 | |
2014 | Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing | Lin M.-T.; Mosier S.L.; Thiess M.; Beierl K.F.; Debeljak M.; LI-HUI TSENG ; Chen G.; Yegnasubramanian S.; Ho H.; Cope L.; Wheelan S.J.; Gocke C.D.; Eshleman J.R. | American Journal of Clinical Pathology | 120 | 108 | |
2020 | Clonal Origin Evaluated by Trunk and Branching Drivers and Prevalence of Mutations in Multiple Lung Tumor Nodules | Rodriguez E.F.; LI-HUI TSENG ; De Marchi F.; Haung J.; Belchis D.; Xian R.; Gocke C.D.; Eshleman J.R.; Illei P.B.; Lin M.-T. | Molecular Diagnosis and Therapy | 1 | 1 |